These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 230106

  • 1. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J.
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [Abstract] [Full Text] [Related]

  • 2. [Worldwide eradication of poliomyelitis].
    Rasch G, Schreier E, Kiehl W, Kurth R.
    Wien Klin Wochenschr; 2001 Oct 30; 113(20-21):839-45. PubMed ID: 11732120
    [Abstract] [Full Text] [Related]

  • 3. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC, Modlin JF.
    Pediatrics; 2006 Aug 30; 118(2):611-8. PubMed ID: 16882814
    [Abstract] [Full Text] [Related]

  • 4. Anomalous observations on IPV and OPV vaccination.
    John TJ.
    Dev Biol (Basel); 2001 Aug 30; 105():197-208. PubMed ID: 11763328
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ.
    Bull World Health Organ; 2004 Jan 30; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [Abstract] [Full Text] [Related]

  • 7. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V, Kyriakopoulou Z, Markoulatos P.
    Expert Rev Vaccines; 2012 May 30; 11(5):609-28. PubMed ID: 22827246
    [Abstract] [Full Text] [Related]

  • 8. Risk management in a polio-free world.
    Bruce Aylward R, Sutter RW, Cochi SL, Thompson KM, Jafari H, Heymann D.
    Risk Anal; 2006 Dec 30; 26(6):1441-8. PubMed ID: 17184391
    [Abstract] [Full Text] [Related]

  • 9. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK, Botham L, Schoub BD.
    Vaccine; 2006 Jul 17; 24(29-30):5670-8. PubMed ID: 16766096
    [Abstract] [Full Text] [Related]

  • 10. Poliomyelitis vaccination benefits--versus risk.
    Assaad F.
    Dev Biol Stand; 1979 Jul 17; 43():141-50. PubMed ID: 520666
    [Abstract] [Full Text] [Related]

  • 11. Safety of oral poliomyelitis vaccine: results of a WHO enquiry.
    Esteves K.
    Bull World Health Organ; 1988 Jul 17; 66(6):739-46. PubMed ID: 3266113
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R, Arras-Reiter C, Arens ER, Quast U, Maass G.
    Wien Med Wochenschr; 1997 Jul 17; 147(19-20):456-61. PubMed ID: 9471843
    [Abstract] [Full Text] [Related]

  • 16. Recommendations for a national policy on poliomyelitis vaccination.
    Nightingale EO.
    N Engl J Med; 1977 Aug 04; 297(5):249-53. PubMed ID: 195207
    [Abstract] [Full Text] [Related]

  • 17. Herd effect and virus eradication with use of killed poliovirus vaccine.
    Salk D.
    Dev Biol Stand; 1981 Aug 04; 47():247-55. PubMed ID: 6262150
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.